Claire Carlier

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 163 citations · Full text

Solid Cancer Patients, Cancer Epidemiology, Disease Risk Assessment +12

Dramatic Changes in Oncology Care Pathways During the COVID-19 Pandemic: The French ONCOCARE-COV Study

Mathias Brügel, Claire Carlier, Christine Essner et al. · The Oncologist · 2020 · 50 citations · Full text

Oncology Care Pathways, Coronavirus Disease 2019, Medicine +15

Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)

Mathias Brügel, Léa Letrillart, Camille Evrard et al. · European Journal of Cancer · 2022 · 25 citations · Full text

Pancreatic Cancer, Medicine, Covid-19 Pandemic +8

Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients

Sidonie Callon, Mathias Brügel, Damien Botsen et al. · Therapeutic Advances in Medical Oncology · 2023 · 16 citations · Full text

Impact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis

Nicolas Laurés, Céline Konecki, Mathias Brügel et al. · Pharmaceutics · 2022 · 14 citations · Full text

Drug Safety, Therapeutic Drug Monitoring, Propension Score Analysis +13